. | FPG-based glycemic status . | . | . | . | . | . | OGTT-based glycemic status . | . | . | . | . | . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | NFG . | All IFG . | IFGnc . | IFGoc . | Diabetes . | P value* . | NFG/NGT . | IFG . | IGT . | IFG/IGT . | Diabetes . | P value . | ||||||||||
n | 638 | 235 | 154 | 81 | 27 | 500 | 74 | 119 | 104 | 103 | ||||||||||||
Male sex (%) | 26 | 52 | 51 | 54 | 56 | <0.0001 | 25 | 45 | 33 | 50 | 57 | <0.0001 | ||||||||||
Age (years) | 41 ± 14a | 51 ± 11 | 50 ± 11a,b | 53 ± 12b | 60 ± 10b | <0.0001 | 39 ± 13d | 48 ± 10d,e | 48 ± 15d,e | 51 ± 11de | 57 ± 12e | <0.0001 | ||||||||||
BMI (kg/m2)† | 26.8 ± 6.5a | 29.5 ± 5.0 | 28.9 ± 4.1a,b | 30.6 ± 6.3b | 32.8 ± 7.9b | <0.0001 | 26.1 ± 5.4d | 28.3 ± 5.2d | 29.2 ± 4.7e | 29.9 ± 4.5e | 30.9 ± 6.3e | <0.0001 | ||||||||||
FPG (mmol/l) | 4.8 ± 0.4c | 6.0 ± 0.4 | 5.8 ± 0.2c | 6.4 ± 0.3c | 7.7 ± 0.7c | <0.0001 | 4.7 ± 0.4f | 5.9 ± 0.2d,e | 5.0 ± 0.3d,e | 5.9 ± 0.4f | 6.5 ± 1.0f | <0.0001 | ||||||||||
2-h plasma glucose (mmol/l) | —- | —- | —- | —- | —- | —- | 5.7 ± 1.1f | 6.5 ± 0.8f | 9.0 ± 0.9d,e | 9.1 ± 0.9de | 13.7 ± 2.4f | <0.0001 | ||||||||||
ISIcomp (AU) | 5.4 ± 3.5c | 2.7 ± 1.7 | 2.9 ± 1.7b | 2.4 ± 1.7b | 2.4 ± 1.9b | <0.0001 | 6.0 ± 3.6f | 3.2 ± 2.1d,e | 3.6 ± 2.4d,e | 2.6 ± 1.4e | 2.7 ± 1.9e | <0.0001 | ||||||||||
HOMA%S | 129 ± 70c | 83 ± 52 | 84 ± 49b | 83 ± 58b | 81 ± 55b | <0.0001 | 137 ± 70f | 99 ± 57d,e | 100 ± 57d,e | 76 ± 44e | 85 ± 62e | <0.0001 | ||||||||||
ΔI30–0/G30 (pmol insulin/mmol glucose) | 47 ± 30c | 37 ± 30 | 40 ± 28c | 30 ± 33c | 15 ± 12c | <0.0001 | 49 ± 30d | 49 ± 42d | 42 ± 28d | 37 ± 22de | 22 ± 17e | <0.0001 | ||||||||||
Adjusted ΔI30–0/G30‡ | 50 ± 27c | 30 ± 28 | 34 ± 28c | 21 ± 29c | 5 ± 31c | <0.0001 | 54 ± 27f | 44 ± 27d,e | 40 ± 26d,e | 29 ± 28f | 13 ± 27f | <0.0001 |
. | FPG-based glycemic status . | . | . | . | . | . | OGTT-based glycemic status . | . | . | . | . | . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | NFG . | All IFG . | IFGnc . | IFGoc . | Diabetes . | P value* . | NFG/NGT . | IFG . | IGT . | IFG/IGT . | Diabetes . | P value . | ||||||||||
n | 638 | 235 | 154 | 81 | 27 | 500 | 74 | 119 | 104 | 103 | ||||||||||||
Male sex (%) | 26 | 52 | 51 | 54 | 56 | <0.0001 | 25 | 45 | 33 | 50 | 57 | <0.0001 | ||||||||||
Age (years) | 41 ± 14a | 51 ± 11 | 50 ± 11a,b | 53 ± 12b | 60 ± 10b | <0.0001 | 39 ± 13d | 48 ± 10d,e | 48 ± 15d,e | 51 ± 11de | 57 ± 12e | <0.0001 | ||||||||||
BMI (kg/m2)† | 26.8 ± 6.5a | 29.5 ± 5.0 | 28.9 ± 4.1a,b | 30.6 ± 6.3b | 32.8 ± 7.9b | <0.0001 | 26.1 ± 5.4d | 28.3 ± 5.2d | 29.2 ± 4.7e | 29.9 ± 4.5e | 30.9 ± 6.3e | <0.0001 | ||||||||||
FPG (mmol/l) | 4.8 ± 0.4c | 6.0 ± 0.4 | 5.8 ± 0.2c | 6.4 ± 0.3c | 7.7 ± 0.7c | <0.0001 | 4.7 ± 0.4f | 5.9 ± 0.2d,e | 5.0 ± 0.3d,e | 5.9 ± 0.4f | 6.5 ± 1.0f | <0.0001 | ||||||||||
2-h plasma glucose (mmol/l) | —- | —- | —- | —- | —- | —- | 5.7 ± 1.1f | 6.5 ± 0.8f | 9.0 ± 0.9d,e | 9.1 ± 0.9de | 13.7 ± 2.4f | <0.0001 | ||||||||||
ISIcomp (AU) | 5.4 ± 3.5c | 2.7 ± 1.7 | 2.9 ± 1.7b | 2.4 ± 1.7b | 2.4 ± 1.9b | <0.0001 | 6.0 ± 3.6f | 3.2 ± 2.1d,e | 3.6 ± 2.4d,e | 2.6 ± 1.4e | 2.7 ± 1.9e | <0.0001 | ||||||||||
HOMA%S | 129 ± 70c | 83 ± 52 | 84 ± 49b | 83 ± 58b | 81 ± 55b | <0.0001 | 137 ± 70f | 99 ± 57d,e | 100 ± 57d,e | 76 ± 44e | 85 ± 62e | <0.0001 | ||||||||||
ΔI30–0/G30 (pmol insulin/mmol glucose) | 47 ± 30c | 37 ± 30 | 40 ± 28c | 30 ± 33c | 15 ± 12c | <0.0001 | 49 ± 30d | 49 ± 42d | 42 ± 28d | 37 ± 22de | 22 ± 17e | <0.0001 | ||||||||||
Adjusted ΔI30–0/G30‡ | 50 ± 27c | 30 ± 28 | 34 ± 28c | 21 ± 29c | 5 ± 31c | <0.0001 | 54 ± 27f | 44 ± 27d,e | 40 ± 26d,e | 29 ± 28f | 13 ± 27f | <0.0001 |
Data are means ± SD. Statistic analyses were χ2 test (sex) and ANOVA with log-transformed data. For FPG-based glycemic status,
P values refer to comparisons of four groups: NFG, IFGnc, IFGoc, and diabetes. Tukey-Kramer homestly significant difference (HSD) test following ANOVA:
different from diabetes;
different from NFG;
different from all other groups. For OGTT-based glycemic status, Tukey-Kramer HSD test following ANOVA:
different from diabetes;
different from NFG/NGT;
different from all other groups.
BMI comparison adjusted by age and sex.
Adjusted by logHOMA%S. AU, arbitrary units; ΔI30–0/G30, ratio of Δinsulin30–0min to glucose30min.